Atorvastatin Calcium Tablet, Film Coated
Product Images NDC 50090-5915

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 50090-5915). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure-01 (Atorvastatin Figure 01)

A line graph showing cumulative incidence (%) over time (years) comparing Atorvastatin and placebo. The graph features two curves with Atorvastatin having a consistently lower incidence than placebo, including a hazard ratio (HR) of 0.64 with confidence interval and a p-value, indicating statistical comparison.*

FDA Label Image

Figure-02 (Atorvastatin Figure 02)

A line graph comparing cumulative hazard percentages over time (years) for Atorvastatin versus placebo groups. The x-axis represents time to first primary endpoint through four years of follow-up, and the y-axis shows cumulative hazard percentage. The Atorvastatin group shows a consistently lower cumulative hazard compared to placebo, with a hazard ratio (HR) of 0.63 and p-value of 0.001 indicated on the graph.*

FDA Label Image

Figure-03 (Atorvastatin Figure 03)

A line graph comparing the percentage of subjects experiencing a major cardiovascular event over time between Atorvastatin 10 mg and Atorvastatin 80 mg. The x-axis represents time to first major cardiovascular endpoint in years (0 to 5), and the y-axis shows the percentage of subjects experiencing the event. The graph includes hazard ratio and p-value statistics.*

FDA Label Image

Structure (Atorvastatin Structure)

Chemical structure of Atorvastatin calcium dihydrate as depicted in the diagram, showing molecular bonds and arrangement of atoms including calcium ion and water of hydration (3H2O).*

FDA Label Image

Label Image (Lbl500905915)

Atorvastatin calcium 40 mg film-coated oral tablets in a blister pack. The label indicates each tablet contains atorvastatin calcium equivalent to 40 mg atorvastatin. The package includes 30 tablets and is labeled by A-S Medication Solutions.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.